Identifying Smoking Status and Smoking Cessation Using a Data Linkage Between the Kentucky Cancer Registry and Health Claims Data
Identifying Smoking Status and Smoking Cessation Using a Data Linkage Between the Kentucky Cancer...
Gallaway, Michael Shayne; Huang, Bin Dr; Chen, Quan Dr; Tucker, Tom; McDowell, Jaclyn Dr; Durbin, Eric Dr; Siegel, David; Tai, Eric
2019-05-16 00:00:00
PURPOSE: Linkage of cancer registry data with complementary data sources can be an informative way to expand what is known about patients and their treatment and improve delivery of care. The purpose of this study was to explore whether patient smoking status and smoking-cessation modalities data in the Kentucky Cancer Registry (KCR) could be augmented by linkage with health claims data. METHODS: The KCR conducted a data linkage with health claims data from Medicare, Medicaid, state employee insurance, Humana, and Anthem. Smoking status was defined as documentation of personal history of tobacco use (International Classification of Diseases, Ninth Revision [ICD-9] code V15.82) or tobacco use disorder (ICD-9 305.1) before and after a cancer diagnosis. Use of smoking-cessation treatments before and after the cancer diagnosis was defined as documentation of smoking-cessation counseling (Healthcare Common Procedure Coding System codes 99406, 99407, G0375, and G0376) or pharmacotherapy (eg, nicotine replacement therapy, bupropion, varenicline). RESULTS: From 2007 to 2011, among 23,703 patients in the KCR, we discerned a valid prediagnosis smoking status for 78%. KCR data only (72%), claims data only (6%), and a combination of both data sources (22%) were used to determine valid smoking status. Approximately 4% of patients with cancer identified as smokers (n = 11,968) and were provided smoking-cessation counseling, and 3% were prescribed pharmacotherapy for smoking cessation. CONCLUSION: Augmenting KCR data with medical claims data increased capture of smoking status and use of smoking-cessation modalities. Cancer registries interested in exploring smoking status to influence treatment and research activities could consider a similar approach, particularly if their registry does not capture smoking status for a majority of patients.
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngJCO Clinical Cancer InformaticsWolters Kluwer Healthhttp://www.deepdyve.com/lp/wolters-kluwer-health/identifying-smoking-status-and-smoking-cessation-using-a-data-linkage-Gj08H0tejj
Identifying Smoking Status and Smoking Cessation Using a Data Linkage Between the Kentucky Cancer Registry and Health Claims Data
PURPOSE: Linkage of cancer registry data with complementary data sources can be an informative way to expand what is known about patients and their treatment and improve delivery of care. The purpose of this study was to explore whether patient smoking status and smoking-cessation modalities data in the Kentucky Cancer Registry (KCR) could be augmented by linkage with health claims data. METHODS: The KCR conducted a data linkage with health claims data from Medicare, Medicaid, state employee insurance, Humana, and Anthem. Smoking status was defined as documentation of personal history of tobacco use (International Classification of Diseases, Ninth Revision [ICD-9] code V15.82) or tobacco use disorder (ICD-9 305.1) before and after a cancer diagnosis. Use of smoking-cessation treatments before and after the cancer diagnosis was defined as documentation of smoking-cessation counseling (Healthcare Common Procedure Coding System codes 99406, 99407, G0375, and G0376) or pharmacotherapy (eg, nicotine replacement therapy, bupropion, varenicline). RESULTS: From 2007 to 2011, among 23,703 patients in the KCR, we discerned a valid prediagnosis smoking status for 78%. KCR data only (72%), claims data only (6%), and a combination of both data sources (22%) were used to determine valid smoking status. Approximately 4% of patients with cancer identified as smokers (n = 11,968) and were provided smoking-cessation counseling, and 3% were prescribed pharmacotherapy for smoking cessation. CONCLUSION: Augmenting KCR data with medical claims data increased capture of smoking status and use of smoking-cessation modalities. Cancer registries interested in exploring smoking status to influence treatment and research activities could consider a similar approach, particularly if their registry does not capture smoking status for a majority of patients.
Journal
JCO Clinical Cancer Informatics
– Wolters Kluwer Health
Published: May 16, 2019
Keywords: bupropion
Recommended Articles
Loading...
References
Late stage cancers in a Medicaid-insured population
Bradley CJ; Given CW; Roberts C
Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study
Ganz PA; Desmond KA; Leedham B
Breast cancer in younger women: Reproductive and late health effects of treatment
Ganz PA; Greendale GA; Petersen L
Linking the Ohio Cancer Incidence Surveillance System with Medicare, Medicaid, and clinical data from home health care and long term care assessment instruments: Paving the way for new research endeavors in geriatric oncology
Koroukian SM
Enhancing Data Systems to Improve the Quality of Cancer Care
Hewitt M; Simon JV (eds)
From Cancer Patient to Cancer Survivor: Lost in Translation
Hewitt M; Greenfield S; Stovall E (eds)
Obtaining smoking histories for population-based studies on multiple primary cancers: Connecticut, 2002
Polednak AP
Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: Case-only design
Prochazka M; Hall P; Gagliardi G
Association between smoking at diagnosis and cause-specific survival in patients with rectal cancer: Results from a population-based analysis of 10,794 cases
Sharp L; McDevitt J; Brown C
Lung cancer in women: Age, smoking, histology, performance status, stage, initial treatment and survival
Radzikowska E; Glaz P; Roszkowski K
Lung cancer and tobacco smoking in Crete, Greece: Reflections from a population-based cancer registry from 1992 to 2013
Sifaki-Pistolla D; Lionis C; Georgoulias V
Emerging issues in smoking among adolescent and adult cancer survivors: A comprehensive review
Klosky JL; Tyc VL; Garces-Webb DM
Determinants of levels and changes of physical functioning in chronically ill persons: Results from the GLOBE Study
Mackenbach JP; Borsboom GJ; Nusselder WJ
Multiple cancer prevalence: A growing challenge in long-term survivorship
Mariotto AB; Rowland JH; Ries LA
Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers
Richardson GE; Tucker MA; Venzon DJ
Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer
Browman GP; Wong G; Hodson I
The problem of cigarette smoking in radiotherapy for cancer in the head and neck
Des Rochers C; Dische S; Saunders MI
Smoking, the missing drug interaction in clinical trials: Ignoring the obvious
Gritz ER; Dresler C; Sarna L
Impact of smoking cessation before resection of lung cancer: A Society of Thoracic Surgeons General Thoracic Surgery Database study
Mason DP; Subramanian S; Nowicki ER
Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: The role of smoking cessation
Kawahara M; Ushijima S; Kamimori T
Second primary cancers related to smoking and treatment of small-cell lung cancer
Tucker MA; Murray N; Shaw EG
Treating tobacco use and dependence: 2008 Update
Tobacco Use and Dependence Guideline Panel
Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis
Underwood JM; Townsend JS; Tai E
Surveillance, Epidemiology, and End Results Program, Site Recode ICD-O-3/WHO 2008 Definition, 2008
National Cancer Institute
Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population
Warren JL; Klabunde CN; Schrag D
Registry Plus Link Plus, 2015
Centers for Disease Control and Prevention
Linking Data for Health Services Research: A Framework and Instructional Guide
Dusetzina SB; Tyree S; Meyer AM
State-specific prevalence of current cigarette smoking and smokeless tobacco use among adults - United States, 2014
Nguyen KH; Marshall L; Brown S
Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers
Shiels MS; Gibson T; Sampson J
Cigarette smoking before and after breast cancer diagnosis: Mortality from breast cancer and smoking-related diseases
Passarelli MN; Newcomb PA; Hampton JM
The Health Consequences of Smoking: 50 Years of Progress: A Report of the Surgeon General
US Department of Health and Human Services
Quit methods used by US adult cigarette smokers, 2014-2016
Caraballo RS; Shafer PR; Patel D
Quitting smoking among adults - United States, 2000-2015
Babb S; Malarcher A; Schauer G
Smoking cessation attitudes and practices among cancer survivors - United States, 2015
Gallaway MS; Glover-Kudon R; Momin B
An assessment of the reliability of race, Hispanic ethnicity, birthplace, and tobacco history data in the Massachusetts cancer registry, 2005-2009
Knowlton R; Gershman S; Solis A
Capture of tobacco use among population-based registries: Findings from 10 National Program of Cancer Registries states
Siegel DA; Henley SJ; Wike JM
Kentucky Cancer Registry
University of Kentucky
Initial National Priorities for Comparative Effectiveness Research
Institute of Medicine Committee on Comparative Effectiveness Research Prioritization Board of Health Care Services
Enhancing cancer registry data for comparative effectiveness research (CER) project: Overview and methodology
Chen VW; Eheman CR; Johnson CJ
ICD-9 tobacco use codes are effective identifiers of smoking status
Wiley LK; Shah A; Xu H
Tobacco product use among adults - United States, 2013-2014
Hu SS; Neff L; Agaku IT
Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies
Crystal S; Akincigil A; Bilder S
Completeness of prescription information in US commercial claims databases
Lauffenburger JC; Balasubramanian A; Farley JF
Quantification of missing prescriptions in commercial claims databases: results of a cohort study
Cepeda MS; Fife D; Denarie M
Assessing the Accuracy of Registry Based Tobacco Use Status and Utility for Patient Recruitment Into Tobacco Trials
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
